Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1·9 million people.

By Anoop Dinesh Shah, C. Langenberg, E. Rapsomaniki, S. Denaxas, M. Pujades-Rodriguez, C. Gale, J. Deanfield, L. Smeeth, A. Timmis, Harry Hemingway. The Lancet, 2015

1,060 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/43d75d71a5767f27efb3903aa7ce3d16bae8c06e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. T. Hansen
2. J. Beulens
3. L. Rydén
4. J. Shaw
5. E. Dal Canto
6. Antonio Ceriello
7. Oliver Schnell
8. F. Cosentino

In Surgery

1. J. Shaw
2. Antonio Ceriello
3. W. Paulus
4. F. Cosentino

Citations in the corpus

• Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications (2019, background): “At the patient level, treating patients with both CVD and T2DM resulted in a cost increase of $3418–9705 /patient/year compared with treating patients with only T2DM.40”
• Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (2018, background): “1%), than vascular events including myocardial infarction (MI) or stroke (26).”
• The burden and risks of emerging complications of diabetes mellitus (2022, background): “Table 2 | Summary of major systematic reviews and original studies reporting an infection risk associated with diabetes mellitus Study diabetes mellitus type Study type included (n) outcome risk associated with diabetes mellitus (95% confidence interval) Fang et al.a (2021)70 All Cohort (12,379) Inf”
• Diabetic vascular diseases: molecular mechanisms and therapeutic strategies (2023, background): “DPVD is often overlooked, yet it is one of the most important and common vascular complications in patients with T2DM.251 In such patients, DPVD increases the risk of not only coronary atherosclerotic events,252 but also major adverse limb events such as amputation.253 DPVD can manifest as diabetic ”
• Using Electronic Health Records for Population Health Research: A Review of Methods and Applications (2015, methodology): “Since its origin in 2011, researchers have used the CALIBER database, which combines the UK’s nationwide CPRD data with CVD procedure registries (33) to evaluate risk factors for 12 different CVDs in 1.3–1.9 million patients (99, 100, 103, 113).”